Skip to content

13G/A filed by BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND L P and 9 other reporting persons reported 4,276,578 GLUE shares, 5% of the class, as of 2026-09-30, in a 13G/A accepted by EDGAR 2026-11-16 21:16:31 UTC.

Accession
0000921895-26-003182
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Stake

Shares
4,276,578
Percent of class
5%
Event date
2026-09-30

How the shares relate across the reporting persons: ambiguous: the persons may hold separate positions, so the group total can be higher. The page shows the largest row.

Read for the filer group BVF INC/IL.

Reporting persons

PersonTypeSole votingShared votingSole dispositiveShared dispositiveAggregatePercent
BIOTECHNOLOGY VALUE FUND L PPN02,243,48102,243,4812,243,4812.6%
BVF I GP LLCOO02,243,48102,243,4812,243,4812.6%
BIOTECHNOLOGY VALUE FUND II LPPN01,681,94501,681,9451,681,9452%
BVF II GP LLCOO01,681,94501,681,9451,681,9452%
Biotechnology Value Trading Fund OS LPPN0283,7670283,767283,7670.3%
BVF Partners OS Ltd.CO0283,7670283,767283,7670.3%
BVF GP HOLDINGS LLCOO03,925,42603,925,4263,925,4264.6%
BVF PARTNERS L P/ILIA,PN04,276,57804,276,5784,276,5785%
BVF INC/ILCO04,276,57804,276,5784,276,5785%
LAMPERT MARK NIN04,276,57804,276,5784,276,5785%